UCP 600 Article 37: Reimbursing Bank Disclaimer

Introduction

The reimbursing bank occupies a peculiar position in documentary credit transactions. It pays money—sometimes significant amounts—but it is not the party that owes the money. Its role is ministerial: follow the issuing bank's authorization, pay the nominated bank, and move on. Article 37 of UCP 600 defines the reimbursing bank's disclaimer, establishing that it assumes no liability beyond executing the authorization it receives. This limited role makes the reimbursing bank's position both simple and risky—simple because its duties are narrow, risky because errors in the authorization it follows can create exposure it did not anticipate.

This guide explains the reimbursing bank's disclaimer under Article 37, what the reimbursing bank is and is not responsible for, and how banks can structure their reimbursing bank relationships to minimize disputes.

Failure Modes

1. Reimbursing Bank Acting Beyond the Scope of Authorization

The most dangerous error for a reimbursing bank is paying more than authorized, paying to the wrong party, or paying before the authorization conditions are met. Article 37's disclaimer does not protect against actions taken outside the authorization's scope.

2. Reimbursing Bank Attempting to Examine Documents

Some reimbursing banks, concerned about fraud risk, attempt to verify that the nominated bank's documents comply with the credit before paying. This is not only outside the reimbursing bank's role under Article 37—it can create liability if the review introduces delay that harms the nominated bank.

3. Failing to Authenticate the Reimbursement Authorization

If a reimbursing bank pays on an unauthorized or forged authorization, it bears the loss. Article 37's disclaimer does not cover payments made on fraudulent instructions. The reimbursing bank must have adequate authentication procedures.

4. Delays in Processing Reimbursement Payments

While Article 37 does not specify an exact timeframe for reimbursement, delays beyond a reasonable period expose the reimbursing bank to claims from nominated banks. The reimbursing bank's processing efficiency directly affects the nominated bank's liquidity.

5. Confusing the Reimbursing Bank Role with a Confirming Bank Role

A reimbursing bank is not a confirming bank. It does not assume an independent payment obligation. Some practitioners misunderstand this distinction, treating the reimbursing bank as having the same payment commitment as a confirmer. This misunderstanding creates unrealistic expectations about the reimbursing bank's obligations.

Resolution Pathways

1. Define Clear Authentication Protocols for Reimbursement Authorizations

Every reimbursing bank should maintain strict authentication procedures for incoming reimbursement authorizations. SWIFT message authentication, callback verification for large amounts, and dual-authorization for payments above defined thresholds are all appropriate safeguards.

2. Do Not Examine Documents—Process Authorizations Only

Reimbursing banks should resist the temptation to examine documents or assess credit compliance. Their role under Article 37 is to execute the issuing bank's authorization. Adding document examination steps creates delays and potential liability that the reimbursing bank's role was designed to avoid.

3. Process Reimbursements Within Defined Timeframes

While Article 37 does not mandate a specific reimbursement timeline, the reimbursing bank should establish internal processing standards (e.g., same-day processing for authorizations received before 2:00 PM local time) and communicate these standards to correspondent banks.

4. Maintain Clear Records of All Authorization Correspondence

Every reimbursement authorization, amendment, and communication should be recorded and retained. These records are the reimbursing bank's primary defense if a dispute arises about what was authorized.

5. Establish Framework Agreements with Regular Correspondent Banks

For banks that frequently serve as reimbursing institutions for the same issuing banks, a framework agreement can define standard procedures, authentication methods, processing timelines, and dispute resolution mechanisms. This reduces per-transaction friction.

6. Monitor Authorization Volumes Against Available Funds

Reimbursing banks should track the cumulative value of outstanding reimbursement authorizations against the issuing bank's available balance or credit line. This prevents situations where the reimbursing bank pays on an authorization that exceeds the issuing bank's funding.

7. Escalate Suspicious Authorizations Immediately

If a reimbursement authorization appears unusual—unusually large amount, unfamiliar beneficiary, or inconsistent with the issuing bank's typical transactions—the reimbursing bank should escalate for verification before processing. This is not document examination; it is fraud prevention within the authorization process.

Conclusion

The reimbursing bank's position under Article 37 is deliberately limited. By disclaiming responsibility for document content and commercial terms, UCP 600 allows the reimbursing bank to function as an efficient payment channel without the burden of commercial risk assessment. This limited role is a feature, not a defect—it enables the reimbursing bank to process payments quickly and reliably.

However, the limited role also means that the reimbursing bank must be disciplined about staying within its boundaries. Acting beyond the authorization, failing to authenticate properly, or attempting to examine documents outside its role creates exposure that Article 37's disclaimer was designed to prevent.

Frequently Asked Questions

1. Can a reimbursing bank refuse to pay if it suspects fraud?

Yes. While Article 37 does not explicitly address fraud, the reimbursing bank should not pay on an authorization it believes may be fraudulent. Refusing payment on suspected fraud is a prudent risk-management step, though it may create friction with the issuing bank if the suspicion proves unfounded.

2. Is the reimbursing bank liable if the issuing bank sends incorrect instructions?

The reimbursing bank is not liable for errors in the issuing bank's instructions, provided it followed those instructions accurately. If the issuing bank's instructions were wrong, the issuing bank bears the responsibility. The reimbursing bank may, however, face indirect consequences such as the need to reverse or correct a payment.

3. Can the nominated bank demand payment directly from the reimbursing bank?

The nominated bank's right to reimbursement depends on the issuing bank's authorization. If the authorization names the nominated bank as the payee, the nominated bank can draw on the reimbursing bank. If the authorization is unclear or names a different payee, the nominated bank may need to seek payment from the issuing bank directly.

4. Does the reimbursing bank need to verify that the credit is still valid?

Article 37 does not require the reimbursing bank to verify credit validity. The reimbursing bank acts on the authorization as received. If the credit has been cancelled or amended, it is the issuing bank's responsibility to notify the reimbursing bank—not the other way around.

5. Can a bank be both a reimbursing bank and a confirming bank for the same credit?

Yes, a bank can serve in both roles, but the obligations are separate. As a confirming bank, it has an independent payment obligation under Article 8. As a reimbursing bank, it has a limited ministerial role under Article 37. The two roles create different duties and different exposure.

Source Notes

Context only — the following sources informed the background understanding for this guide but were not directly reproduced or copied:

• ICC UCP 600 publication (International Chamber of Commerce, July 2007)
• ICC Academy eBook: Uniform Rules for Documentary Credits (UCP 600), published December 2024
• ICC Academy: Certified UCP 600 Specialist (CUCP) program materials, published July 2025
• ICC Commentary on UCP 600 (International Chamber of Commerce, August 2019)
• ICC Academy: Understanding "CONFIRM" vs. "MAY ADD" in documentary credits under UCP 600, published August 2025